Table 1.
MICs for the P. aeruginosa isolates used in this study
Isolate | MIC (mg/liter)a |
Cephalosporinase and carbapenemase typing | MDRb | |
---|---|---|---|---|
Colistin | Imipenem | |||
ATCC 27853c | 1 | 2 | Negative | No |
19147 n/m | 128 | 4 | IMP and CTX-M positived | Yes |
19056 muc | 0.5 | 4 | Negative | Yes |
20509 n/mc | 0.5 | 1 | Negative | No |
19271 n/mc | 2 | 32 | Negative | Yes |
20891 n/mc | 1 | 16 | Negative | Yes |
CLSI breakpoints for colistin were ≤2 mg/liter for susceptibility, 4 mg/liter for intermediacy, and ≥8 mg/liter for resistance. For imipenem, the breakpoints were ≤4 mg/liter for susceptibility, 8 mg/liter for intermediacy, and ≥16 mg/liter for resistance (10).
Defined as diminished susceptibility to ≥2 of the following 5 drug classes: antipseudomonal cephalosporins, antipseudomonal carbapenems, β-lactam-β-lactamase inhibitor combinations, antipseudomonal fluoroquinolones, and aminoglycosides (40).
Colistin heteroresistant. Heteroresistance to colistin was defined as the existence, in an isolate for which the colistin MIC was ≤2 mg/liter, of subpopulations able to grow in the presence of >2 mg/liter colistin (55).
Contains genes encoding an IMP-type carbapenemase and a CTX-M-type ESBL.